Current Environment:

Warning

Recall Alert

There is a voluntary recall of some nasal sprays. Learn more

Summary

This study will measure plasma concentrations of dexmedetomidine, fentanyl, morphine and midazolam in pediatric patients supported with extracorporeal membrane oxygenation (ECMO) aiming to understand the pharmacokinetics of these drugs in this setting.

Conditions

Drug Effect

Recruitment Status

Recruiting

Eligibility Criteria

Inclusion Criteria:

supported on ECMO
receiving one or a combination of the following drugs dexmedetomidine, fentanyl, midazolam or morphine as part of sedation management

Exclusion Criteria:

-none

Intervention

Intervention Type

Intervention Name

Drug

Dexmedetomidine

Drug

Fentanyl

Drug

Midazolam

Drug

Morphine

Gender

All

Min Age

0 Days

Max Age

17 Years

Download Date

July 20, 2023

Principal Investigator

Viviane Nasr

Primary Contact Information

Viviane Nasr, MD

617-355-6225

viviane.nasr@childrens.harvard.edu

For more information on this trial, visit clinicaltrials.gov.

Contact

For more information and to contact the study team:

Pharmacokinetics of Sedatives and Analgesics During Extracorporeal Membrane Oxygenation (ECMO) Support NCT03593408 Viviane Nasr, MD 617-355-6225 viviane.nasr@childrens.harvard.edu